VRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.
Valeant Pharmaceuticals International Inc's cash flow for capital expenditures for the three months ended in Jun. 2015 was $-56 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2015 was $-438 Mil.
Valeant Pharmaceuticals International Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jun. 2015 was -113.9 (Sep. 2014 ) + -153.6 (Dec. 2014 ) + -114.6 (Mar. 2015 ) + -56 (Jun. 2015 ) = $-438 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Valeant Pharmaceuticals International Inc Annual Data
Valeant Pharmaceuticals International Inc Quarterly Data